Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (61-70 of 216) with videos related to

Pageof 22
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 28, 2020
A sticky proposition: The endothelial glycocalyx and von Willebrand factorSeon Jae Choi, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|December 18, 2018
Fifty years newDavid Lillicrap, James H Morrissey
Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
Evidence-based medicine in thrombosis and hemostasis: ISTH to the foreDavid Lillicrap, James H Morrissey
Blood|July 19, 2014
FVIII stabilization: VWF D'D3 will doLaura L Swystun, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|January 6, 2021
Changes for 2021James H Morrissey, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|November 19, 2021
COVID-19 - Two years inDavid Lillicrap, James H Morrissey
Journal of Thrombosis and Haemostasis : JTH|September 19, 2022
The future of basic science research into a leading cause of disability and deathJames H Morrissey, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|December 26, 2021
Changes and challenges in the new yearJames H Morrissey, David Lillicrap
Jvs-Vascular Science|January 14, 2022
Role of von Willebrand factor in venous thromboembolic diseaseAlison Michels, David Lillicrap, Michael Yacob
Seminars in Thrombosis and Hemostasis|May 1, 2004
Preclinical animal models for hemophilia gene therapy: predictive value and limitationsFiona E M Rawle, David Lillicrap
Pageof 22

Showing results (61-70 of 216) with videos related to

Sort By:
Pageof 22
Journal of Thrombosis and Haemostasis : JTH|January 28, 2020
A sticky proposition: The endothelial glycocalyx and von Willebrand factorSeon Jae Choi, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|December 18, 2018
Fifty years newDavid Lillicrap, James H Morrissey
Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
Evidence-based medicine in thrombosis and hemostasis: ISTH to the foreDavid Lillicrap, James H Morrissey
Blood|July 19, 2014
FVIII stabilization: VWF D'D3 will doLaura L Swystun, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|January 6, 2021
Changes for 2021James H Morrissey, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|November 19, 2021
COVID-19 - Two years inDavid Lillicrap, James H Morrissey
Journal of Thrombosis and Haemostasis : JTH|September 19, 2022
The future of basic science research into a leading cause of disability and deathJames H Morrissey, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|December 26, 2021
Changes and challenges in the new yearJames H Morrissey, David Lillicrap
Jvs-Vascular Science|January 14, 2022
Role of von Willebrand factor in venous thromboembolic diseaseAlison Michels, David Lillicrap, Michael Yacob
Seminars in Thrombosis and Hemostasis|May 1, 2004
Preclinical animal models for hemophilia gene therapy: predictive value and limitationsFiona E M Rawle, David Lillicrap
Pageof 22